Table 2. Frequency of therapeutic control of blood pressure and cholesterol level in CHD patients from the Münster region in EUROASPIRE I, II, and III.
| Control of blood pressure*1 | Control of cholesterol*2 | ||||||||||||||||
| EUROASPIRE | EUROASPIRE | ||||||||||||||||
| I | II | III | I | II | III | ||||||||||||
| Age (years) | |||||||||||||||||
| <60 | 66/158 (41.8) | 61/162 (37.7) | 96/176 (54.6) | 6/69 (8.7) | 31/135 (23.0) | 87/163 (53.4) | |||||||||||
| ≥60 | 59/157 (37.6) | 42/191 (22.0) | 95/249 (38.2) | 7/65 (10.8) | 23/127 (18.1) | 126/220 (57.3) | |||||||||||
| Sex | |||||||||||||||||
| Female | 26/70 (37.1) | 15/71 (21.1) | 25/84 (29.8) | 1/32 (3.1) | 9/60 (15.0) | 26/73 (35.6) | |||||||||||
| Male | 99/245 (40.4) | 88/282 (31.2) | 166/341 (48.7) | 12/102 (11.8) | 45/202 (22.3) | 187/310 (60.3) | |||||||||||
| Diagnostic group | |||||||||||||||||
| ACB | 34/85 (40.0) | 22/93 (23.7) | 58/123 (47.2) | 2/29 (6.9) | 11/73 (15.1) | 63/107 (58.9) | |||||||||||
| AMI | 30/90 (33.3) | 34/91 (37.4) | 6/13 (46.2) | 2/44 (4.6) | 20/67 (29.9) | 8/13 (61.5) | |||||||||||
| PCI | 40/74 (54.1) | 26/89 (29.2) | 122/278 (43.9) | 7/43 (16.3) | 18/67 (26.9) | 138/254 (54.3) | |||||||||||
| Ischemia | 21/66 (31.8) | 21/80 (26.3) | 5/11 (45.5) | 2/18 (11.1) | 5/55 (9.1) | 4/9 (44.4) | |||||||||||
| Total | 125/315 (39.7) | 103/353 (29.2) | 191/425 (44.9) | 13/134 (9.7) | 54/262 (20.6) | 213/383 (55.6) | |||||||||||
*1Blood pressure <140/90 mmHg (<130/80 mmHg) in non-diabetics (diabetics) with antihypertensive medication;
*2 total cholesterol <175 mg/dL in patients with lipid-lowering drugs; ACB, aortocoronary bypass surgery; AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; ischemia, myocardial ischemia.